» Authors » Martin A Schreiber

Martin A Schreiber

Explore the profile of Martin A Schreiber including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 257
Citations 4974
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maiga A, Lin H, Wisniewski S, Brown J, Moore E, Schreiber M, et al.
JAMA Netw Open . 2025 Jan; 8(1):e2457506. PMID: 39888614
Importance: While national guidelines recommend avoidance of hypoxia, hypotension, and hypocarbia in the prehospital care of traumatic brain injury (TBI), limited data validate the association of these adverse physiologic events...
2.
Chipman A, Luther J, Guyette F, Cotton B, Cannon J, Schreiber M, et al.
J Trauma Acute Care Surg . 2025 Jan; 98(3):393-401. PMID: 39865522
Introduction: Whole blood resuscitation is associated with survival benefits in observational cohort studies. The mechanisms responsible for outcome benefits have not been adequately determined. We sought to characterize the achievement...
3.
Van Gent J, Clements T, Rosario-Rivera B, Wisniewski S, Cannon J, Schreiber M, et al.
J Trauma Acute Care Surg . 2025 Jan; 98(2):236-242. PMID: 39760660
Background: Blood shortages and utilization stewardship have motivated the trauma community to evaluate futility cutoffs during massive transfusions (MTs). Recent single-center studies have confirmed meaningful survival in ultra-MT (≥20 U)...
4.
Papa L, McKinley W, Valadka A, Newman Z, Nordgren R, Pramuka P, et al.
JAMA Netw Open . 2024 Sep; 7(9):e2431115. PMID: 39230905
Importance: Data on the performance of traumatic brain injury (TBI) biomarkers within minutes of injury are lacking. Objectives: To examine the performance of glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal...
5.
Newman Z, Ogbeifun V, Barbosa C, McKinley W, Benjamin A, Munar M, et al.
J Surg Res . 2024 Sep; 302:798-804. PMID: 39226704
Introduction: Tranexamic acid (TXA) is an antifibrinolytic drug that has been demonstrated to reduce head injury-related mortality when given within 2 h of injury in patients with traumatic brain injury...
6.
Farrell D, McConnell K, Zilberman-Rudenko J, Behrens B, Mcloud S, Cook M, et al.
JAMA Netw Open . 2024 Aug; 7(8):e2427786. PMID: 39145978
Importance: Patients with trauma exhibit a complex balance of coagulopathy manifested by both bleeding and thrombosis. Antithrombin III is a plasma protein that functions as an important regulator of coagulation....
7.
Sperry J, Luther J, Okonkwo D, Vincent L, Agarwal V, Cotton B, et al.
J Neurosurg . 2024 Jul; :1-10. PMID: 39076152
Objective: Traumatic brain injury (TBI) and hemorrhage are responsible for the largest proportion of all trauma-related deaths. In polytrauma patients at risk of hemorrhage and TBI, the diagnosis, prognosis, and...
8.
Holcomb J, Butler F, Schreiber M, Taylor A, Riggs L, Krohmer J, et al.
Transfusion . 2024 Jul; 64(8):1543-1550. PMID: 39031029
No abstract available.
9.
Deshpande D, McKinley W, Benjamin A, Schreiber M, Rowell S
J Surg Res . 2024 Jul; 301:359-364. PMID: 39024715
Introduction: Tranexamic acid (TXA) administered within 2 h of injury reduces mortality in traumatic brain injury (TBI) with intracranial hemorrhage. TXA also reduces the seizure threshold in a dose-dependent manner....
10.
Gurney J, Cap A, Holcomb J, Staudt A, Tadlock M, Polk T, et al.
J Trauma Acute Care Surg . 2024 Jul; 97(2S Suppl 1):S31-S36. PMID: 38996415
Battlefield lessons learned are forgotten; the current name for this is the Walker Dip. Blood transfusion and the need for a Department of Defense Blood Program are lessons that have...